News
Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges
Exelixis Inc (EXEL) reports robust financial results driven by the cabozantinib franchise, while navigating competitive and ...
15d
Livewire Markets on MSNHow professional investors value stocks and why they ignore 'earnings beats'If you're confused by stock price movements and the business media's role in them, you're not alone. Here's a stock price ...
Operating margins improved significantly, fueled by the company's higher plan pricing. Forward guidance looks strong on revenue, but just OK on profitability. Wall Street had high expectations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results